Virion\Serion
Private Company
Funding information not available
Overview
Virion\Serion is a well-established, privately-held German diagnostics company with over 45 years of experience. It has successfully built a dual business model, combining the development of finished IVD test kits with the production of critical raw materials, serving both end-users and other diagnostic manufacturers. The company's strengths lie in its broad infectious disease portfolio, deep expertise in antigen manufacturing, and recent successful transition to the EU's stringent IVDR regulatory framework. Its outlook is stable, supported by a resilient business model and ongoing demand for infectious disease testing.
Technology Platform
Immunoassay-based diagnostics (ELISA, CLIA) with core expertise in high-quality antigen and antibody production for serological testing. Platforms include manual test kits, automated solutions, and software tools.
Opportunities
Risk Factors
Competitive Landscape
Virion\Serion competes in the fragmented infectious disease diagnostics segment. It faces competition from large, diversified players like Abbott, Roche, and Siemens Healthineers, as well as other specialized serology companies. Its competitive differentiation lies in its exceptionally broad pathogen portfolio, deep antigen manufacturing expertise, and its unique position as both a kit manufacturer and a key raw material supplier.